Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High – Marketwire (press release)
By Dr. Matthew Watson
Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High Marketwire (press release) NEW YORK, NY--(Marketwire - Feb 1, 2013) - A sharp increase in drug approvals and mergers and acquisitions combined to create a bull market for the Biotechnology Industry in 2012. The iShares NASDAQ Biotechnology Index (IBB), the SPDR S&P Biotech ... |
Uncategorized
Comments Off on Biotechnology Industry Soars in 2012 as FDA Drug Approvals at a 15-Year High – Marketwire (press release) |
February 3rd, 2013
This author published 6152 posts in this site.Share
Comments are closed.
Personalized Gene Medicine
| Mesenchymal Stem Cells
| Stem Cell Treatment for Multiple Sclerosis
| Stem Cell Treatments
| Board Certified Stem Cell Doctors
| Stem Cell Medicine
| Personalized Stem Cells Therapy
| Stem Cell Therapy TV
| Individual Stem Cell Therapy
| Stem Cell Therapy Updates
| MD Supervised Stem Cell Therapy
| IPS Stem Cell Org
| IPS Stem Cell Net
| Genetic Medicine
| Gene Medicine
| Longevity Medicine
| Immortality Medicine
| Nano Medicine
| Gene Therapy MD
| Individual Gene Therapy
| Affordable Stem Cell Therapy
| Affordable Stem Cells
| Stem Cells Research
| Stem Cell Breaking Research